Penn Medicine Translational
Neuroscience Center (PTNC)

Funding Opportunities, Courses, etc.

(Note: these lists are updated regularly so check back often)

ANNOUNCEMENTS

Michael J. Fox Foundation for Parkinson's Research Announces New Fox Insight Clinical Trial
Fox Insight is an online clinical study where people with Parkinson's disease and their loved ones share information that could transform the search for better treatments. The online clinical study is designed to capture the daily Parkinson's experience and amplify the patient voice in research and care. More than 13,000 people are now part of Fox Insight, sharing information that could transform the search for better treatments. Fox Insight is open to people with Parkinson's and all volunteers.
Click here for more information: https://foxinsight.michaeljfox.org/

 

The Michael Brown Penn-GSK Postdoctoral Fellowship Award Program
The Perelman School of Medicine at the University of Pennsylvania and GlaxoSmithKline are proud to announce the commencement of The Michael Brown Penn-GSK Postdoctoral Fellowship Award Program.

Named in honor of alumnus Michael S. Brown (C ’62, M ’66, HON ’86), who shared the 1985 Nobel Prize for Physiology or Medicine, the new program will support outstanding Perelman School of Medicine post-doctoral scientists dedicated to collaborative research in biomedical sciences with the goal of discovering, developing and delivering novel therapies for human diseases.

The program will pair up to three awardees (and his/her academic mentor) with a GSK scientist, who will serve as an industry partner.  Recipients of this honor will receive stipend, research funding, travel support and career development guidance.

Eligible Perelman School of Medicine candidates should be incoming, first- or second-year post-docs with a PhD and/or MD and strong publication and research accomplishment at the time of application.  Identification of a potential co-mentor at GSK and/or inclusion of an ongoing collaborative project with GSK will strongly enhance the application.

DEADLINE: Applications are due to the Biomedical Postdoctoral Programs Office (postdoc@pennmedicine.upenn.edu) by 5 PM on Tuesday, January 2, 2018.

For more information regarding the program and application process, click here. Please contact Viviane Martin, PhD, Director of Penn Center for Innovation Licensing Group (martinv@upenn.edu) with questions.

 

HIGHLIGHTED FUNDING

Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint for Neuroscience Research: Dynamic Neuroimmune Interactions in the Transition from Brain Function to Dysfunction (R01) - NOT-AA-17-006
Organization: NIH
Activity Code: R01
FOA is expected to be published in fall 2017 with an expected application due date in winter 2017

Global Brain and Nervous System Disorders Research Across the Lifespan (R21) - PAR-17-313
Organization: NIH
Activity Code: R21
Letter of Intent Due: 30 days prior to the application due date
Application Due Date: November 7, 2017 (AIDS and non-AIDS)

Global Brain and Nervous System Disorders Research Across the Lifespan (R01) - PAR-17-314
Organization: NIH
Activity Code: R01
Letter of Intent Due: 30 days prior to the application due date
Application Due Date: November 7, 2017 (AIDS and non-AIDS)

 

 

 

EXTERNAL FUNDING

NIH BRAIN Initiative Active Funding — ​Click here for Active Funding Opportunities

Private Foundation Funding — click here (updated 08-10-17)

NIH Funding Opportunities — click here (updated 07-21-17)

NSF Funding Opportunities — https://www.nsf.gov/funding/advanced_funding_search.jsp

 

INTERNAL FUNDING

 

 

Additional Funding Opportunities can be found at the following links:

Perelman School of Medicine funding opportunities page

ITMAT funding opportunities page

 

AWARDS

 

WEBINARS

 

COURSES/TRAINING PROGRAMS

News & Announcements

  • CNST Leadership Change Announcment

Events

More events

Search